Marketing of the Product Sample Clauses

Marketing of the Product. VII.1 BIOVENTUS undertakes to use commercially reasonable efforts to launch the PRODUCT in the United States within [***] months from EFFECTIVE DATE. VII.2 In marketing the PRODUCT, BIOVENTUS shall exercise the same diligence, which BIOVENTUS employs in marketing its own products of similar market potential, taking into account efficacy, safety, approved labeling, the competitiveness of alternative products in the marketplace, the patent and other proprietary position of the product, profitability, and other relevant factors commonly considered in similar circumstances. VII.3 The PRODUCT shall be promoted in accordance with the therapeutic indications set forth in the FDA APPROVAL, as well as in compliance with any applicable law and regulation in force in the TERRITORY.

Marketing of the Product. The Company shall use best commercial efforts to market, distribute and sell the Product, stand alone or in combination with other products owned or licensed or distributed by Company, in the Territory during the Initial Term of this Agreement including any term extensions. All expenses incurred in connection with the formulation, promotion, marketing and advertising of the Product in the Territory shall be borne solely and exclusively by Company.

Marketing of the Product. COMPANY undertakes to launch the PRODUCT in the TERRITORY within **** months from the COMMENCEMENT DATE of this Agreement. COMPANY shall inform IBSA of the LAUNCHING DATE of the PRODUCT with a notice of at least **** and will not launch the PRODUCT earlier than the date that is **** after the EFFECTIVE DATE without the prior consent of IBSA..

Marketing of the Product. 7.1 The Distributor shall be entitled to resell the Product to its customers at such prices as it may determine, subject to all applicable price controls imposed by governmental authorities in the Territory. 7.2 In connection with the promotion and marketing of the Product the Distributor shall: 7.2.1 make clear in all dealings with customers, prospective customers and other persons that it is acting as Distributor of the Product and not as an agent of EUSA; 7.2.2 provide EUSA each month with reports in such form as EUSA may reasonably require of sales of the Product by the Distributor (made in the preceding month and since the last report) and containing such other information as EUSA may reasonably require; 7.2.3 from time to time consult with EUSA's representatives for the purpose of assessing the state of the market in the Territory and permit them to inspect any premises and/or documents used by the Distributor in connection with the sale of the Product; 7.2. 4 be responsible for producing at its own cost supplies of all materials necessary for the marketing and promotion of the Product in the Territory and at the request of EUSA provide copies of such sales aids, including catalogues, sales brochures and sales manuals, as relate to the Product;

Marketing of the Product. Beginning on the later of the US Implant Date or January 1, 2021, Distributor agrees to use its best efforts and devote such time as may be necessary to promote, distribute and sell the Product that Distributor distributes in the Territory. Subject to Section 4(d), Distributor agrees to, at its cost and expense: (i) employ or contract, directly or indirectly, a sufficient number of trained (by Supplier, as set forth in Section 4(d), at Distributor’s request), and qualified personnel to promote and sell the Product in the Territory; and (ii) maintain a professional sales and service organization as necessary to sell the Product in the Territory and provide training and customer service for the Product in the Territory. Following the later of the US Implant Date or January 1, 2021, Distributor will meet the Minimum Sales Condition and the Minimum Implant Condition as set forth in EXHIBIT B attached hereto.

Marketing of the Product. LICENSEE shall use commercially reasonable efforts to market the Product in the Territory, at its own expense, and to: (i) advertise and promote sales of the Product, using techniques and methods which are customary in the pharmaceutical industry for the marketing of pharmaceutical Product and to promote and advertise the Product in the same manner as it promotes and advertises other similar product which it manufactures or distributes; (ii) make and maintain regular and sufficient contact with present and future customers of the Product; (iii) maintain such sales organization, facilities, personnel and training as may be required to ensure fulfillment of its obligations under this Agreement; (iv) conduct its obligations under this Agreement in a manner that will reflect favorably upon LICENSEE, HAMELN and the Product so as to preserve the goodwill and customer’s acceptance of the Products.

Marketing of the Product. ALTA VISTA authorizes lnfomedia to market, sell and sub-license the work using all the distribution channels available to it within the assigned territory, both traditional and non-traditional, and to promote this in any medium of communication.

Marketing of the Product. 11.1 Wyeth-Ayerst shall use [CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION] efforts to promote the sales of the Product in the Territory. 11.2 As soon as practical before NDA approval, and by the first day of each calendar year at the latest, Wyeth-Ayerst shall provide Neurogen with Wyeth- Ayerst's good faith sales forecast for the forthcoming two (2) year period. Such forecast shall include Wyeth-Ayerst's intended promotional activities for each ensuing year of reference. Thereafter on an annual basis until the sixth year of sales in major countries of the world, Wyeth-Ayerst will continue to provide to Neurogen such rolling two (2) year sales forecasts. 11.3 In its written and verbal information to the medical profession and patients, Wyeth-Ayerst shall represent the Product in a manner consistent with the Technological Data.

Marketing of the Product. Product Manager 5.01 Within sixty (60) days after the Effective Date, Biovail shall appoint a Product Manager experienced in the marketing of pharmaceutical products in Canada as the person primarily responsible for the co-ordination of the Marketing of the Product in Canada. The Product Manager shall be responsible for dealing on a day to day basis with the personnel of Hemispherx responsible for the Product. Biovail may, at any time by written notice to Hemispherx, replace that Product Manager without the consent of Hemispherx. The Product Manager may from time to time and in the sole discretion of Biovail delegate certain aspects of his/her responsibilities to other employees of Biovail. Canadian Pre-marketing Studies 5.02 Biovail shall use its commercially reasonable best efforts to enlist at least 10 physicians to assist in conducting pre-marketing studies for the Canadian Emergency Release ("ER") program. Biovail shall encourage those physicians to enroll a total of at least 40 patients suffering from CFS in the Canadian ER program within 12 months after the date that all regulatory requirements for the Canadian ER program have been fulfilled. Biovail's Marketing Obligations 5.03 Biovail shall introduce the Product within ninety (90) days after the issue of an NOC for the Product, subject to receipt of commercial supplies of the Product from Hemispherx. 5.04 Biovail shall use diligent efforts, and shall devote to Marketing the Product such resources as are necessary to create a Market for the Product in the Territory, including such Marketing, Detailing and continuing health education programs relating to the Product. Biovail shall conduct such additional activities as presentations at scientific and medical meetings using promotional materials, and other personal and non-personal efforts. Biovail shall organize regular symposia or scientific meetings, directed at opinion leaders in all metropolitan areas with the frequency required to keep these opinion leaders informed about new research data generated relating to the Product. 5.05 Subject only to the provisions of this Agreement, Biovail shall control and be responsible for the distribution and sale of the Product in the Territory. Biovail shall be responsible for the day-to-day Marketing decisions and activities including, without limitation, developing and implementing the Marketing plans for the Product and developing and implementing the tactical plans for all advertising, educational, sales a...

Marketing of the Product. Interactive and Advent, each at its own expense, will cooperate in marketing the use of the Product in conjunction with Interactive’s information services. However, neither party shall have any obligation to the other to undertake marketing efforts. Advent shall be responsible for supplying documentation to clients describing the necessary procedures to access the Datafeed interface and Interactive’s financial databases. Interactive will supply Advent’s clients with a description of the Datafeed product and an outline description of the financial information to which they may have access.